Board of Directors
The Board is the decision-making body of the network. It is elected by the Council at the annual conference, and its term is one year.
Current Board
Current Board
Ms. Ling-Chen (Cathy) Chien
Center for Drug Evaluation (CDE) · Taiwan
Prof. apt. Auliya A. Suwantika
Indonesia Health Technology Assessment Committee (InaHTAC), Ministry of Health · Indonesia
Mr. Benjamin Ong
Agency for Care Effectiveness (ACE), Ministry of Health · Singapore
Dr. Izzuna Mudla Mohamed Ghazali
Malaysia Health Technology Assessment Section (MaHTAS), Ministry of Health · Malaysia
Dr. Miyoung Choi
National Evidence-based Healthcare Collaborating Agency (NECA) · South Korea
Dr. Sitanshu Sekhar Kar
Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) · India
Dr. Takashi Fukuda
Center for Outcomes Research and Economic Evaluation for Health (C2H), National Institute of Public Health · Japan
Dr. Wendy Babidge
Australian Safety and Efficacy Register of New Interventional Procedures – Surgical (ASERNIP-S) · Australia
Secretariat
The Secretariat processes membership applications, supports the President in the activities of the network including the annual conference, maintains the list of approved members and communicates with members on all matters related to the network.
HTAsiaLink Transition Secretariat is hosted by Center for Drug Evaluation (CDE) since 2026.
Secretariat history
| Host organisation | Period |
|---|---|
| Center for Drug Evaluation (CDE), Taiwan | 2026– |